Fennec Pharmaceuticals Inc. (FENC)

NASDAQ: FENC · Real-Time Price · USD

Compare

7.69

+0.03 (0.39%)

At close: Jan 26, 2026, 4:00 PM EST

7.71

+0.02 (0.26%)

After-hours: Jan 26, 2026, 4:10 PM EST

Fennec Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	38.79	47.54	21.25	1.54	-	0.17	Upgrade
Revenue Growth (YoY)	-21.39%	123.69%	1284.50%	-	-	-	Upgrade
Cost of Revenue	2.67	3.18	1.26	0.09	-	-	Upgrade
Gross Profit	36.12	44.35	19.99	1.45	-	0.17	Upgrade
Selling, General & Admin	40.5	41.48	32.71	20.51	12.24	12.95	Upgrade
Research & Development	0.28	0.31	0.06	3.53	4.98	5.11	Upgrade
Operating Expenses	40.78	41.79	32.76	24.04	17.22	18.06	Upgrade
Operating Income	-4.66	2.57	-12.77	-22.59	-17.22	-17.89	Upgrade
Interest Expense	-2.8	-4.16	-3.68	-1.13	-0.14	-0.41	Upgrade
Interest & Investment Income	0.96	1.68	0.44	0.2	0.05	0.09	Upgrade
Currency Exchange Gain (Loss)	-	-0.08	0.01	-0.01	-0.01	-	Upgrade
EBT Excluding Unusual Items	-6.51	0.01	-16.01	-23.53	-17.32	-18.21	Upgrade
Gain (Loss) on Sale of Investments	-0.07	-0.08	-0.04	-0.18	-0.03	0.1	Upgrade
Pretax Income	-6.57	-0.07	-16.05	-23.71	-17.35	-18.11	Upgrade
Income Tax Expense	0.37	0.37	-	-	-	-	Upgrade
Net Income	-6.94	-0.44	-16.05	-23.71	-17.35	-18.11	Upgrade
Net Income to Common	-6.94	-0.44	-16.05	-23.71	-17.35	-18.11	Upgrade
Shares Outstanding (Basic)	28	27	27	26	26	24	Upgrade
Shares Outstanding (Diluted)	28	27	27	26	26	24	Upgrade
Shares Change (YoY)	1.25%	2.71%	1.14%	1.03%	9.71%	19.14%	Upgrade
EPS (Basic)	-0.25	-0.02	-0.60	-0.90	-0.67	-0.76	Upgrade
EPS (Diluted)	-0.26	-0.02	-0.60	-0.90	-0.67	-0.76	Upgrade
Gross Margin	93.12%	93.30%	94.08%	94.40%	-	100.00%	Upgrade
Operating Margin	-12.02%	5.40%	-60.09%	-1471.60%	-	-10520.59%	Upgrade
Profit Margin	-17.89%	-0.92%	-75.50%	-1544.89%	-	-10652.35%	Upgrade
EBITDA	-4.33	3.6	-	-	-	-	Upgrade
EBITDA Margin	-11.15%	7.57%	-	-	-	-	Upgrade
D&A For EBITDA	0.34	1.03	-	-	-	-	Upgrade
EBIT	-4.66	2.57	-12.77	-22.59	-17.22	-17.89	Upgrade
EBIT Margin	-12.02%	5.40%	-60.09%	-	-	-	Upgrade
Revenue as Reported	38.79	47.54	21.25	-	-	-	Upgrade

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q